To hear about similar clinical trials, please enter your email below

Trial Title: Promoting CT Engagement for Pancreatic Cancer With App

NCT ID: NCT06252545

Condition: Pancreas Cancer

Conditions: Official terms:
Pancreatic Neoplasms

Conditions: Keywords:
ethnicity
black
application

Study type: Interventional

Study phase: N/A

Overall status: Recruiting

Study design:

Allocation: Non-Randomized

Intervention model: Parallel Assignment

Intervention model description: There will be 2 groups: 20 subjects with pancreas carcinoma for phone interviews and 6 for user testing the first version of the application..

Primary purpose: Health Services Research

Masking: None (Open Label)

Intervention:

Intervention type: Behavioral
Intervention name: semistructured interviews
Description: Black subjects with pancreatic cancer will provide insight on their experience discussing clinical trials and preferences for communicating clinical trial information
Arm group label: Interview Group

Intervention type: Behavioral
Intervention name: feedback
Description: Black subjects with pancreatic cancer will provide feedback on mHealth app prototype.
Arm group label: User Testing Group

Summary: To develop a culturally tailored informational mobile application and test whether it will increase participation among Black pancreatic cancer subjects in clinical trial discussions with their care team. This project aims to identify and address barriers to enrollment of Black subjects in pancreatic cancer clinical trials using a culturally informed mobile health application to promote participation. The clinical trial education and communication needs of Black people with pancreatic cancer will be determined. A new mHealth application for clinical trial education and communication tailored to subject needs will be developed. It was hypothesized that a culturally tailored informational mobile application will increase the participation of Black subjects in clinical trial discussions with their care team among the target population. This study focuses on Black pancreatic cancer subjects, who experience higher mortality rates and lower clinical trial participation than White subjects. Research shows that the disparity between clinical trial participation is in part due to inequitable recruitment practices. This study will use mobile application technology (mHealth app) as an educational, communication, audit, and feedback tool to promote patient-initiated clinical trial discussions among Black people with pancreatic cancer and their cancer care team.

Criteria for eligibility:
Criteria:
Inclusion Criteria Participants must meet the following inclusion criteria in order to participate in communication & education interview component of the study: 1. Informed consent obtained to participate in the study 2. 18 years or older 3. English speaking 4. Able and willing to participate in a 1-hour interview 5. History of pancreatic cancer diagnosis 6. Identify as Black Exclusion Criteria: All participants meeting any of the following exclusion criteria will be excluded from the study: 1. Inability to read and speak English 2. Dementia altered mental status, or any psychiatric condition that would prohibit understanding or rendering of informed consent as determined by the study physician.

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: UNC Lineberger Comprehensive Cancer Center

Address:
City: Chapel Hill
Zip: 27599
Country: United States

Status: Recruiting

Contact:
Last name: Lori Stravers

Phone: 919-966-4432
Email: lori_stravers@med.unc.edu

Contact backup:
Last name: Brent Henderson

Phone: +1 919-966-7706
Email: brent_henderson@med.unc.edu

Investigator:
Last name: Jen Jen Yeh, MD
Email: Principal Investigator

Facility:
Name: Medical College Of Wisconsin

Address:
City: Milwaukee
Zip: 53226
Country: United States

Status: Recruiting

Contact:
Last name: Christian Campbell

Phone: +1 414-955-1423
Email: ccampbell@mcw.edu

Investigator:
Last name: Ugwuji Maduekwe, MD, MMSc, MPH
Email: Principal Investigator

Start date: February 2, 2024

Completion date: October 31, 2025

Lead sponsor:
Agency: UNC Lineberger Comprehensive Cancer Center
Agency class: Other

Collaborator:
Agency: Lustgarten Foundation
Agency class: Other

Source: UNC Lineberger Comprehensive Cancer Center

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06252545
http://unclineberger.org/patientcare/clinical-trials/clinical-trials

Login to your account

Did you forget your password?